Novartis

Dr. Jean-Marc F. Blanchard's picture

Getting High on China: The High Cost of Low-Priced Drugs for Pharma Firms?

Recently, foreign pharmaceutical makers such as AbbVie, AstraZeneca, Novartis, Sanofi, and Roche slashed the prices of a large number of drugs sold in China, the world’s second largest drug market.

MNCs in the News-2018-01-08

Chinese drug approval authorities likely to approve several blockbuster foreign drugs in 2018. Hyundai Motor Group faces declining sales growth in 2018 in large part due to political and economic challenges in China. China State-Owned Assets Supervision and Advisory Commission (SASAC) to issue new guidelines to improve behavior of state-owned enterprises (SOEs) in various areas. United States (US) Committee on Foreign Investment in the United States (CFIUS) concerns leads China’s Ant Financial and US MoneyGram to terminate the former’s acquisition of the latter. Japan’s Toshiba Corp sells floundering US nuclear business Westinghouse, which went bankrupt after regulations and other factors stalled many of its projects, to Canada’s Brookfield. US legal process for Takata Corp.’s US unit coming to completion, which should allow company to make payouts to claimants who suffered from Takata’s faulty airbags. Korea urges US policy makers to reconsider the US International Trade Commission's recommended special tariff on imported Korean washers. Lotte Group struggling to shed its politically troubled Chinese hypermarket chain after talks with Thai conglomerate failed to produce agreeable sale price. Indonesia’s state-owned energy company Pentamina took back control of Indonesia’s largest oil and gas block helping Jakarta to expand its control over domestic energy production. Indonesia’s Investment Coordinating Board launches several measures to spur 10 to 14 percent year on year growth in FDI. Thailand’s Board of Investment expects FDI into its EEC to continue to grow as new EEC policies are implemented and foreign companies become familiar with EEC requirements. Chinese FDI into Malaysia is expected to move out of infrastructure and property development and into new sectors due to China’s Belt and Road Initiative. Japanese Ambassador touts that Japanese firms have a good chance to win Kuala Lumpur-Singapore high-speed rail project. Vietnam’s Ministry of Transport has set a new deadline for long delayed Chinese-funded Cat Linh rail project

MNCs in the News-2015-02-06

China Banking Regulatory Commission (CBRC) encourages Chinese banks to use more domestic technology. China’s moves to fight tax avoidance by MNCs raise fears among foreign firms in China. American Chamber of Commerce in Beijing raises concern about Chinese agricultural policies. Chinese railway firm pursues railway project cancellation compensation from Mexico while Chinese agencies express hope Chinese rights will be protected. Japan’s Ministry of Health, Labor, and Welfare will slap business suspension order on Novartis. Japanese car companies suffering from US West Coast port labor strikes. World Economic Forum (WEF) ranks Korea among the lowest in terms of policy transparency. Foreign business associations in Korea lobby Korea to control labor costs and unions. Foreign companies charge Korean Fair Trade Commission (KFTC) is biased.